×
About 1,093 results

ALLMedicine™ Antithrombin LII Center

Research & Reviews  369 results

Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection
https://clinicaltrials.gov/ct2/show/NCT04651400

Mar 10th, 2023 - Multicentre, multinational, non-interventional, observational, retrospective, patient record study to evaluate changes in coagulation parameters in patients with severe COVID-19 infection receiving/not treatment with antithrombin (AT) III

Effect of a Combined Drug Approach on the Severity of Ischemia-Reperfusion Injury Durin...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975910
JAMA Network Open; Meurisse N, Mertens M et. al.

Mar 1st, 2023 - In a porcine model of liver transplant, a combined drug approach that targeted the donor graft and graft recipient reduced ischemia-reperfusion injury, a major hurdle to the success of liver transplant. To assess the effect of a clinical form of a...

Renal Vein Thrombosis
http://emedicine.medscape.com/article/460752-overview

Mar 1st, 2023 - Practice Essentials Renal vein thrombosis (RVT) most commonly occurs in patients with nephrotic syndrome (defined as urinary protein loss >3 g/day, hypoalbuminemia, hypercholesterolemia, and edema) due to the loss of antithrombin III (ATIII) in th...

Renal Vein Thrombosis
https://emedicine.medscape.com/article/460752-print

Mar 1st, 2023 - Practice Essentials Renal vein thrombosis (RVT) most commonly occurs in patients with nephrotic syndrome (defined as urinary protein loss >3 g/day, hypoalbuminemia, hypercholesterolemia, and edema) due to the loss of antithrombin III (ATIII) in th...

Renal Vein Thrombosis
https://emedicine.medscape.com/article/460752-overview

Mar 1st, 2023 - Practice Essentials Renal vein thrombosis (RVT) most commonly occurs in patients with nephrotic syndrome (defined as urinary protein loss >3 g/day, hypoalbuminemia, hypercholesterolemia, and edema) due to the loss of antithrombin III (ATIII) in th...

see more →

Drugs  3 results see all →

Clinicaltrials.gov  48 results

Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection
https://clinicaltrials.gov/ct2/show/NCT04651400

Mar 10th, 2023 - Multicentre, multinational, non-interventional, observational, retrospective, patient record study to evaluate changes in coagulation parameters in patients with severe COVID-19 infection receiving/not treatment with antithrombin (AT) III

Are Uterine Fibroids Pro-thrombotic?
https://clinicaltrials.gov/ct2/show/NCT05607602

Nov 7th, 2022 - Uterine Fibroids (UF) are benign uterine tumours, also known as leiomyomas. They are estimated to affect up to 80% of women of reproductive age. UF more commonly occur in women of Afro-Caribbean ethnicity. UF may be asymptomatic or associated with...

Safe Use of Heparin Sodium in Patients With Chronic Renal Failure.
https://clinicaltrials.gov/ct2/show/NCT01229072

Nov 3rd, 2022 - The Heparin form a complex with a plasma protein, antithrombin III (ATIII), which is an endogenous anticoagulant. This complex inhibits the formation of thrombin and accelerates its destruction. Moreover, heparin and other proteases ATIII inactiva...

Influence of Cardiac Implantable Electronic Devices on the Hemostatic System
https://clinicaltrials.gov/ct2/show/NCT04499612

Oct 27th, 2022 - 250 patients of similar age, gender, and ethnicity will be divided into five groups: Group A1-3: 150 patients with indications for cardiac implantable electronic device (CIED) implantation; Group B: 50 patients with an CIED implanted 8-10 years ag...

Antithrombin III in Infectious Disease Caused by COVID-19
https://clinicaltrials.gov/ct2/show/NCT04899232

Sep 7th, 2022 - The purpose of this research study is to see if participants who have SARS-CoV-2 and low levels of AT3 in the blood will benefit by being given AT3.

see more →

News  15 results

31st Annual San Antonio Breast Cancer Symposium
https://www.onclive.com/view/on_31st_meeting_sabcs

Dec 5th, 2020 - Couldn’t make it to the Henry B. Gonzalez Convention Center in San Antonio, TX December 10—14, 2008 for the San Antonio Breast Cancer Symposium (SABCS)? Don’t worry, we’ve got you covered, with highlights straight from the convention center, thank...

Fast Five Quiz: Direct Oral Anticoagulant Therapy for Atrial Fibrillation
https://reference.medscape.com/viewarticle/924960_2

Apr 2nd, 2020 - Figure 1. The physiological cascade of blood clotting. Three of the four DOAC agents approved as anticoagulation therapy for patients with AF work through direct FXa inhibition (rivaroxaban, apixaban, edoxaban) or direct thrombin inhibition (dabig...

Heparin-Induced Bullous Hemorrhagic Dermatosis Confined to the Oral Mucosa
https://www.mdedge.com/dermatology/article/202369/contact-dermatitis/heparin-induced-bullous-hemorrhagic-dermatosis
Hannah B. Harris, MD, Benjamin J. Kurth, MD et. al.

Jun 5th, 2019 - Heparin is a naturally occurring anticoagulant and is commonly used to treat or prevent venous thrombosis or the extension of thrombosis. 1 Heparin is composed of 15-kDa chains of complex polysaccharides with repeating pentasaccharide sequences.

Fast Five Quiz: Test Your Knowledge of Venous Thromboembolism
https://reference.medscape.com/viewarticle/902400_2

Dec 3rd, 2018 - Nephrotic syndrome is one of several disease states that increase a patient's risk of developing VTE. VTE associated with nephrotic syndrome appears to be due to a hypercoagulable state resulting from urinary loss of anticoagulant proteins, togeth...

More Lab Tests Deemed Inappropriate
https://www.staging.medscape.com/viewarticle/887645

Oct 26th, 2017 -                           The American Society of Clinical Pathology (ASCP) has added five tests to the list it considers unnecessary or potentially harmful, as part of the Choosing Wisely campaign. The list has now grown to 20 recommendations. Th...

see more →

Patient Education  2 results see all →